Literature DB >> 8876636

Modelling human leukemia and lymphoma in severe combined immunodeficient (SCID) mice: practical applications.

D J Flavell1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8876636     DOI： 10.1002/(SICI)1099-1069(199606)14:2<67::AID-HON567>3.0.CO;2-U

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  4 in total

Review 1.  Human cancer growth and therapy in immunodeficient mouse models.

Authors:  Leonard D Shultz; Neal Goodwin; Fumihiko Ishikawa; Vishnu Hosur; Bonnie L Lyons; Dale L Greiner
Journal:  Cold Spring Harb Protoc       Date:  2014-07-01

Review 2.  Immunodeficient mouse models of lymphoid tumors.

Authors:  Kazunori Imada
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

3.  Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice.

Authors:  D J Flavell; S L Warnes; A L Noss; S U Flavell
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

4.  The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure.

Authors:  Samantha Kendrick; Hyun-Jin Kang; Mohammad P Alam; Manikandadas M Madathil; Prashansa Agrawal; Vijay Gokhale; Danzhou Yang; Sidney M Hecht; Laurence H Hurley
Journal:  J Am Chem Soc       Date:  2014-03-07       Impact factor: 15.419
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.